NCT06390852 · Interventional trial
Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)
Overall registry status Active not recruiting
Phase 2
Conditions Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma
Delaware Valley sites
- ECOG-ACRIN Cancer Research Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory